Catalyst Wire Dossier Catalyst Wire Dossier

IOpener-Melanoma Test

· Pamgene International B.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IOpener-Melanoma Test, covering 2025-02-28 to 2025-02-28. Get the full timeline:

Most recent: Clinical Trial Update: Observational Study of Patients With Advanced Melanoma (Skin Cancer) to Assess if IOpener®-Melanoma Test Can Predict Response to Immunotherapy.

See pricing